FUJIFILM Corporation's Life Sciences Group companies, a portfolio of businesses offering products, services and comprehensive ...

SUMITOMO Pharma is preparing to run early stage, clinical trials in the US to assess the safety of the treatment. Sumitomo Pharma Co. shares surged by the most since 1992 after results of a study ...

The movement can be attributed to discussions of a potential stake sale by the bank to the Japan-based Sumitomo ... the logo and/or wordmark of ‘Ola’," according to an exchange filing on Monday. The ...

MARLBOROUGH, Mass., April 29, 2025 /PRNewswire/ -- Sumitomo Pharma America, Inc. (SMPA) presented new, positive data from the COURAGE Phase 3 open-label extension study of vibegron (GEMTESA®) in men ...

– Data include results from COURAGE Phase 3 and COMPOSUR Phase 4 studies of vibegron (GEMTESA®) – MARLBOROUGH, Mass., April 29, 2025 /PRNewswire/ -- Sumitomo Pharma America, Inc. (SMPA ...

MARLBOROUGH, Mass., April 29, 2025 /PRNewswire/ -- Sumitomo Pharma America, Inc. (SMPA) presented new, positive data from the COURAGE Phase 3 open-label extension study of vibegron (GEMTESA®) in ...

Sumitomo Pharma Co. shares surged by the most since 1992 after results of a study showed the safety and potential benefits of stem cells used to treat Parkinson’s disease. The stock jumped 20% ...

April 14, 2025 /PRNewswire/ -- Sumitomo Pharma America, Inc. (SMPA) today announced it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute ...

TOKYO -- Japanese trading house Marubeni said Tuesday it will purchase a majority stake in Sumitomo Pharma's drug sales business in Asia for roughly 45 billion yen ($301 million). Sumitomo Pharma ...